Literature DB >> 11458501

CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations.

M Ogawa1, F Tajima, T Ito, T Sato, J H Laver, T Deguchi.   

Abstract

For more than a decade it was believed that hematopoietic stem cells express CD34. However, this dogma was recently challenged by the observation that stem cells of normal adult mice are CD34-. In order to clarify the controversy, we carried out systematic examination of stem cells by using C57BL/6 mice that are congenic for Ly-5. As reported previously, stem cells in the normal adult mice were CD34-. However, stem cells stimulated in vivo by 5-fluorouracil injection or in vitro by a combination of interleukin-11 and steel factor were CD34+. The activated CD34+ stem cells reverted to CD34- when the recipients' marrow achieved steady state. The majority of G-CSF-mobilized stem cells also were CD34+ and reverted to CD34- under steady-state conditions. Most recently, we examined the developmental changes of stem cell CD34 expression. In order to gain information on the total population of stem cells we prepared CD34+ and CD34- populations of mononuclear cells without prior enrichment and studied their engrafting potentials. All stem cells from perinatal to 5-week-old mice were CD34+. In 7-week-old mice CD34- stem cells began to emerge, and the majority of the stem cells were CD34- in the 10- and 20-week-old mice. An estimated 20% of the adult stem cells expressed CD34. These observations provide insight into the current controversy regarding CD34 expression by adult hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458501     DOI: 10.1111/j.1749-6632.2001.tb03583.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

Review 1.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

Review 2.  Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis.

Authors:  Sebastian George Barton Furness; Kelly McNagny
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Surface antigen phenotypes of hematopoietic stem cells from embryos and murine embryonic stem cells.

Authors:  Shannon L McKinney-Freeman; Olaia Naveiras; Frank Yates; Sabine Loewer; Marsha Philitas; Matthew Curran; Peter J Park; George Q Daley
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

4.  Awakening dormant haematopoietic stem cells.

Authors:  Andreas Trumpp; Marieke Essers; Anne Wilson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

Review 5.  Hematopoietic Stem Cell Heterogeneity.

Authors:  Roland Jurecic
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 6.  A revisionist history of adult marrow stem cell biology or 'they forgot about the discard'.

Authors:  P Quesenberry; L Goldberg
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

7.  Embryonic stem cell-derived hematopoietic stem cells.

Authors:  Yuan Wang; Frank Yates; Olaia Naveiras; Patricia Ernst; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-15       Impact factor: 11.205

Review 8.  Proinflammatory stem cell signaling in cardiac ischemia.

Authors:  Jeremy L Herrmann; Troy A Markel; Aaron M Abarbanell; Brent R Weil; Meijing Wang; Yue Wang; Jiangning Tan; Daniel R Meldrum
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

9.  Gene expression fluctuations in murine hematopoietic stem cells with cell cycle progression.

Authors:  Gerri J Dooner; Gerald A Colvin; Mark S Dooner; Kevin W Johnson; Peter J Quesenberry
Journal:  J Cell Physiol       Date:  2008-03       Impact factor: 6.384

10.  KIT receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion.

Authors:  Shayu Deshpande; Benedikt Bosbach; Yasemin Yozgat; Christopher Y Park; Malcolm A S Moore; Peter Besmer
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.